SAC could face $1bn+ withdrawals
  • X
  • LinkedIn
  • Email
  • Show more sharing options
  • Print
  • X
  • LinkedIn
  • Email
  • Free trial
  • Log in

SAC could face $1bn+ withdrawals

Steven Cohen's SAC Capital Advisors is being sued by investors in the pharmaceutical company Elan, who allege that the hedge fund engaged in illegal insider trading in the firm's options before clinical trial results were released.

Subscribers, log in here:

Fuel a smarter strategy with our actionable market intelligence

      • Gain a competitive edge and accelerate decision-making
      • Be empowered by insights that transform confusion to clarity
      • Uncover growth opportunities and prepare for potential threats
      • Fuel a smarter strategy for business growth
Gift this article